ETN029 Datasheet DC Chemicals

Description	ETN029 represents an innovative macrocyclic peptide therapeutic specifically engineered to target the atypical Notch ligand DLL3. This target exhibits highly selective overexpression on the surface of small cell lung cancer (SCLC) and neuroendocrine prostate cancer (NEPC) cells, though its relatively low expression density presents significant drug development challenges.
Cat.No	DC67582
Name	ETN029

Chemical Properties

CAS
Formula
MW
Storage	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

References

Return Policy

If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.

Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.

Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com